Filing Flows › BioScience Health Innovations (BHIC) › Q4 2024
BioScience Health Innovations (BHIC) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 13, 2025
BioScience Health Innovations (BHIC) reported revenue of $610K for the fourth quarter 2024 (Q4 2024), +101% from a year earlier and +7% from the quarter before. Operating margin was 1.6%, net earnings $10K (1.6% of revenue).
BioScience Health Innovations, Q4 2024: revenue $610K (+101% year over year), operating margin 1.6%, net earnings $10K, operating cash flow −$50K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $610K | +7% | +101% |
| Gross profit | $339K | -20% | +43% |
| Operating profit | $10K | -82% | — |
| Net earnings | $10K | -82% | — |
| Operating cash flow | −$50K | — | — |
What changed
Revenue was $610K in Q4 2024, up 101% year over year and up 7% from the previous quarter.
Gross margin was 55.6%, down 22.3 points from a year earlier. Operating profit was $10K, a 1.6% margin (up 14.3 points year over year). Operating expenses grew 20% against revenue growth of 101%. The fastest-growing cost line was Other operating costs (+190%). Net earnings were $10K. The effective tax rate was 0.0%.
Operating cash flow was −$50K. Working capital and other items used $60K.
Questions
What was BioScience Health Innovations' revenue in the fourth quarter 2024?
BioScience Health Innovations (BHIC) reported revenue of $610K for the fourth quarter 2024 (Q4 2024), +101% from a year earlier and +7% from the quarter before.
Was BioScience Health Innovations profitable in the fourth quarter 2024?
Operating profit was $10K (1.6% of revenue) and net earnings $10K.